3
Announcements
Trials
Browse
Landscape
Status
Withdrawn
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
7
Observational
1
Expanded_access
1
Sponsor
Cancer Type
Other hematologic neoplasm
5
Classical hematology
4
Lymphoid
1
Conditions
Lymphoma
399
Precursor Cell Lymphoblastic Leukemia-Lymphoma
398
Leukemia, Lymphocytic, Chronic, B-Cell
215
Lymphoma, Non-Hodgkin
204
Lymphoma, Follicular
193
Lymphoma, Large B-Cell, Diffuse
180
Leukemia
164
Hodgkin Disease
160
Multiple Myeloma
118
Neoplasms
97
Leukemia, Myeloid, Acute
87
Lymphoma, Mantle-Cell
78
Burkitt Lymphoma
67
Myelodysplastic Syndromes
64
Lymphoma, B-Cell, Marginal Zone
64
Lymphoma, T-Cell, Cutaneous
62
Breast Neoplasms
62
Mycosis Fungoides
55
Recurrence
52
Lymphoma, B-Cell
50
Hematologic Neoplasms
50
Sezary Syndrome
43
Waldenstrom Macroglobulinemia
41
Myeloproliferative Disorders
39
Neoplasms, Plasma Cell
38
Lung Neoplasms
34
Lymphoma, Large-Cell, Immunoblastic
33
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
32
Lymphoma, T-Cell, Peripheral
29
Leukemia, Hairy Cell
29
Interventions
Glucose Tolerance Test
1
Continuous Glucose Monitoring
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Hemoglobinopathies
×
Lymphoid
×
Clear all
NCT03141398
2017-07-26
CGMs
Hamad Medical Corporation
Withdrawn